International Journal of Women's Health and Reproduction Sciences

Home Aim and Scope Instructions to Authors Editorial Policies Editorial Board Authorship Agreement Form Open Access and Copyright

Jul 2021, Vol 9, Issue 3

CURRENT ISSUE ARCHIVE AHEAD OF PRINT / ACCEPTED ARTICLE MOST VIEWED ARTICLES NEWS RELATED LINKS

Advanced Search

For Author's & Reviewer's

Committee on Publication
Ethics (COPE) Flowchart

Recommendations for the Conduct

COPE: Reviewers

World Association of Medical Editors(WAME)

EQUATOR Resources : Reviewers

Poll

How do you find the scientific quality of the published articles on our web site?

Very good

Good

Fair

Bad

Very bad

Original Article
Investigating the Factors Affecting the Severity of Neuropathic Pain Before and After the Coronavirus Infection in Patients Having Breast Cancer Surgery
Saeid Charsouei¹, Loghman Ghaderi², Hassan Mohammadipour Anvari³, Reza Eghdam Zamiri⁴
¹Department of Neurology, Medicine Faculty, Tabriz University of Medical Sciences Tabriz, Iran ²Department of Surgery, Medicine Faculty, Kordestan University of Medical Sciences Tabriz, Iran ³Department of Anesthesiology and Operating Room, Allied Medical Sciences Faculty Tabriz University of Medical Sciences Tabriz, Iran ⁴Department of Radiology, Medicine Faculty, Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences Tabriz, Iran
IJWHR 2021; 9: 190-194 DOI: 10.15296/ijwhr.2021.35 Viewed : 1969 times Downloaded : 1633 times. Keywords : Neuropathic Pain, COVID-19, Breast Surgery, Anxiety
Full Text(PDF) \| Related Articles
Abstract

Objectives: Approximately one-third of women having breast surgery experience neuropathic pain although no study has so far identified its risk factors. It seems that the coronavirus infection increases the likelihood of neuropathic pain through influencing the neuropsychological system. Therefore, the current study aimed to investigate factors affecting the severity of neuropathic pain before and after coronavirus disease 19 (COVID-19) in patients who had breast cancer surgery. Materials and Methods: The current descriptive-analytical study was conducted six months before June 4, 2020. In total, 40 women having breast surgery participated in this study. Postoperative neuropathic pain and its influencing factors were evaluated using demographic tools, Spielberger anxiety, and a 36-item short-form health survey for measuring the quality of life (QoL). Finally, data were analyzed by multivariate regression. Results: Neuropathic pain significantly increased during the COVID-19 pandemic. Mastectomy (P = 0.009), removal of lymph nodes (P = 0.011), number of radiotherapy sessions (P = 0.003), history of chemotherapy (P = 0.009), disease stage (P = 0.015), hidden anxiety (P = 0.005), and explicit anxiety (P = 0.001), and all domains of QoL (P < 0.05) significantly predicted neuropathic pain. Conclusions: In general, adverse effects of coronavirus pandemic reduced the QoL while increasing anxiety (hidden and explicit), thus leading to an increase in the severity of postoperative neuropathic pain.